![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.25 | 9.09% | 15.00 | 14.50 | 15.50 | 15.25 | 13.75 | 13.75 | 3,403,515 | 11:15:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 2.19M | -20.13M | -0.0773 | -1.94 | 35.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/1/2024 12:07 | circa 33% retrace perfectly ususal then next leg up added a few sovs | ![]() seagreen | |
08/1/2024 11:31 | 1 code for the believers lol hehe | ![]() dealer55 | |
08/1/2024 11:29 | defo some big consistent buying I see. | ![]() dealer55 | |
08/1/2024 11:17 | Sun damaged Red Astra man :D | ![]() g2theary | |
08/1/2024 11:16 | This is what happened to POS in August 2023... breakout on good news... to 4.5p then retraced to 3p In September it hit 30p | ![]() thiopia | |
08/1/2024 11:15 | Little tick up... | ![]() dealer55 | |
08/1/2024 11:14 | Some background on current ctDNA testing below. You can see where Parsortix could elivate the current standard of testing on the market. The more you research, the more AN's comment of "may turn out to be grounbreaking" look all the more achievable...... This could become a Salesmans wet dream....... CtDNA tests for minimal residual disease are still being studied. They have shown promise in colorectal, lung, urothelial (urinary system), and breast cancers. They are not yet considered part of standard care for breast cancer, but that could change as more information becomes available through clinical trials. One MRD ctDNA test, Signatera, is covered by Medicare for monitoring people with stage IIB or higher breast cancer that is hormone receptor-positive, HER2-positive, or triple-negative. So it’s important to be aware of these tests, where the research currently stands, and their potential advantages and disadvantages. Mr K. | ![]() mrkeysersoze | |
08/1/2024 11:04 | One for the diary's guys.... Snapshot bullet points: ANGLE breakthrough provides deeper, personalised insights on cancer progression ANGLE PLC: Making solid commercial progress ANGLE CEO says latest cancer results "may turn out to be groundbreaking" Mr K. | ![]() mrkeysersoze | |
08/1/2024 10:55 | just have to hold, IMO | ![]() dealer55 | |
08/1/2024 10:49 | Yeah I thought the site was down there | ![]() dave4545 | |
08/1/2024 10:48 | 10mins and no trade.... Cue tumble weed..... | ![]() boris cobaka | |
08/1/2024 10:33 | G SPANNER in the works is likely. Let’s have a look at him and the rest of the muppets by week end. | ![]() astra1vision | |
08/1/2024 10:17 | 20p next stop?. | ![]() thehitman1 | |
08/1/2024 09:59 | who is selling at 23p ???? | ![]() dealer55 | |
08/1/2024 09:59 | No 30p trade today as being sold off | ![]() robizm | |
08/1/2024 09:54 | I did get lucky and trade that up from the morning dip :) but did pick up a few too early at 26.2p :) but added twice today ;) GL | ![]() g2theary | |
08/1/2024 09:53 | Just added some more for that 30p trade ;) | ![]() g2theary | |
08/1/2024 09:44 | not sure, all the positivity over the weekend, MM must read it and do the opposite, I'm holding tho, still a bit peeved that the 37p spike happened. | ![]() dealer55 | |
08/1/2024 09:42 | No I can see that :D hummm what next | ![]() g2theary | |
08/1/2024 09:20 | it didn't tho... | ![]() dealer55 | |
08/1/2024 09:03 | About to smash through 26p on to 30+ ;) | ![]() g2theary | |
08/1/2024 08:57 | Loves his curry :D | ![]() g2theary |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions